( inase deficiency and chronic granulomat...)Development of gene therapy

inase deficiency and chronic granulomatous disease. There are also initial indicators that point to the efficacy of gene therapy in treating chronic lymphatic leukaemia and haemophilia B. But successes in clinical testing come with their share of setbacks, such as the currently slight margin of therapeutic effectiveness over unwanted side effects. This underscores the necessity to carefully assess risks and benefits and also shows that there is still a dire need for more research on gene therapy. Basic research should be conducted in direct collaboration across disciplines, using animal models and clinical studies. An acute need for research exists, especially regarding the development of efficient and safe vectors for gene transfer.

'"/>

Source:Deutsche Forschungsgemeinschaft


Page: 1 2
Related biology news :

1. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
2. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
3. Development of portable infectious disease detector
4. Unexpressed But Indispensable -- The DNA Sequences That Control Development
5. UCSD-Salk Team Show Protein’s Gene-Silencing Role In Development of Nervous System
6. Analysis Of Human Genome To Predict The Development Of Illnesses
7. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
8. Insight into natural cholesterol control suggests novel cholesterol-lowering therapy
9. Two chemicals boost immune cells ability to fight HIV without gene therapy
10. Elevated temperature enhances success of viral cancer therapy
11. HIV mortality in India drops with introduction of generic antiretroviral therapy